Publiceret .

Om økonomiske evalueringer

af Jesper Madsen

Man diskuterer ofte hvordan man skal måle effekten af en given alternativ behandling. Men når man tager de samfundsøkonomiske briller på, må man operere med en række andre faktorer, som intet har med selv behandlingen at gøre.

Principper, begreber og udfordringer er systematiseret i denne ”drejebog” vedr. evaluering af udbytte og omkostninger ved brug af alternativ behandling. Den er skrevet af bl.a. Patricia Herman fra  University of Arizona. Hun har fokus på sundhedsøkonomi og har skrevet tre bøger om økonomiske evalueringsmetoder.

Se artiklen fra "Global Advances in Health and Medicine" her.

Citat fra artiklen:
Complementary and integrative medicine (CIM) is usually defined as those approaches to health that are outside mainstream medicine. In overcoming this exclusion, CIM faces a number of challenges of credibility as well as the need to show safety, effectiveness, and cost-effectiveness. Therefore, effectiveness trials and economic evaluations of CIM may have to meet a higher quality bar than those of conventional medicine. There is also limited funding for all research but especially for CIM. This is why well-designed and well-done effectiveness trials are essential and economic evaluations should be added wherever possible. It is also imperative that the results of these efforts be well reported. It is only by generating high-quality evidence that CIM can be considered at the healthcare policy table.